Thymus-Dependent Lymphocyte Function in Patients With Hepatitis-Associated Antigen

Giustino, V.; Dudley, F. J.; Sherlock, Sheila

doi:10.1016/s0140-6736(72)92212-x

Cited by 77 publications

(15 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only one carrier had low titers of antibody and a low IgG level. In this respect, our results differ from those of others [4][5][6]. This difference is probably related to our stricter criteria of selection, which excluded individuals with biological signs of hepatic disease.…”

Section: Discussioncontrasting

confidence: 99%

See 1 more Smart Citation

Lack of Leukocyte Migration Inhibition by Hepatitis B Antigen and Normal Nonspecific Immunoreactivity in Asymptomatic Carriers

Desaules

Frei

Libanska

et al. 1976

Journal of Infectious Diseases

View full text Add to dashboard Cite

The immune response to hepatitis B surface antigen (RB s Ag) was studied in 25 asymptomatic carriers by the leukocyte migration-inhibition (LMI) test in agarose. In the presence of purified RB s Ag, inhibition was demonstrated in only four of 25 carriers, in contrast to 24 of 28 patients who cleared the antigen after acute infection with hepatitis B. Tuberculin purified protein derivative (PPD) was also used as an antigen for the LMI test in these carriers. Inhibition was demonstrated in only 12 of 25 individuals who had positive PPD skin tests, in contrast to all of 14 normal noncarrier individuals with positive PPD skin tests and none of 12 normal noncarrier individuals with negative PPD skin tests. A nonspecific immunological investigation of the asymptomatic carriers gave normal results. The lack of an immune response to HB s Ag was thought to be responsible for the persistence of the antigen and also for the absence of symptoms.About 0.2<;'0 of the blood donors in this part of Europe are carriers of hepatitis B surface antigen (HB s Ag). Some of these asymptomatic carriers have slightly elevated levels of transaminases, whereas others do not exhibit any biochemical sign of hepatic cytolysis but have slight histological abnormalities of the liver. A third group of these carriers are normal, both biochemically and histologically [1][2][3].Since HB s Ag is usually associated with acute hepatitis and disappears at the time of recovery, it is difficult to explain how the antigen can persist in the third (normal) group of carriers without damaging the liver. The fact that HB s Ag can persist in two conditions as different as the healthy carrier state and chronic hepatitis is also problematical.

show abstract

Section: Discussioncontrasting

confidence: 99%

“…The nonspecific cellular immune response was found to be impaired by some authors [4][5][6] and normal by others [1,7,8]. The specific immune response to HB s Ag has also been studied in vitro in blood from a limited number of carriers.…”

mentioning

confidence: 99%

Lack of Leukocyte Migration Inhibition by Hepatitis B Antigen and Normal Nonspecific Immunoreactivity in Asymptomatic Carriers

Desaules

Frei

Libanska

et al. 1976

Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…T-lymphocyte function as measured by PHA-induced blast transformation and leukocyte migration inhibition has been reported to be abnormal in HB.Ag-positive patients with chronic active and chronic persistent hepatitis (1)(2)(3). In these studies, however, autologous sera was a component in the assay.…”

Section: Resultsmentioning

confidence: 99%

“…Thymus-derived or T-lymphocyte' function may be an important determinant in the host response to hepatitis infection (1)(2)(3). The persistence of hepatitis-B surface antigen (HB.Ag) in the serum following an attack of hepatitis B is frequently associated with the development of chronic active and chronic persistent hepatitis (4).…”

Section: Introductionmentioning

confidence: 99%

“…The persistence of hepatitis-B surface antigen (HB.Ag) in the serum following an attack of hepatitis B is frequently associated with the development of chronic active and chronic persistent hepatitis (4). Cell-mediated immunity in chronic carriers of hepatitis-B antigen and in patients with chronic active hepatitis (CAH) has been reported to be abnormal when assessed by in vitro assays such as phytohemagglutinin (PHA)-stimulated lymphocyte blast transformation and leukocyte migration inhibition (1)(2)(3)5). Thus, studies were performed to assess the role of T-lymphocyte function in patients with acute and chronic hepatitis and controls.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation